These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 16877359

  • 1. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K, Bretteville A, Leroy K, Bégard S, Brion JP, Hamdane M, Buée L.
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [Abstract] [Full Text] [Related]

  • 2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, Behar L, Ben-Hur T, Avraham Y, Berry E, Segal M, Ginzburg I, Abramsky O.
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [Abstract] [Full Text] [Related]

  • 3. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q, Zhang X, Sun A.
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [Abstract] [Full Text] [Related]

  • 4. Divergent phosphorylation pattern of tau in P301L tau transgenic mice.
    Deters N, Ittner LM, Götz J.
    Eur J Neurosci; 2008 Jul; 28(1):137-47. PubMed ID: 18662339
    [Abstract] [Full Text] [Related]

  • 5. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.
    Van der Jeugd A, Ahmed T, Burnouf S, Belarbi K, Hamdame M, Grosjean ME, Humez S, Balschun D, Blum D, Buée L, D'Hooge R.
    Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950
    [Abstract] [Full Text] [Related]

  • 6. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
    Chong SA, Benilova I, Shaban H, De Strooper B, Devijver H, Moechars D, Eberle W, Bartic C, Van Leuven F, Callewaert G.
    Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
    [Abstract] [Full Text] [Related]

  • 7. Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.
    Taniguchi T, Doe N, Matsuyama S, Kitamura Y, Mori H, Saito N, Tanaka C.
    FEBS Lett; 2005 Oct 24; 579(25):5704-12. PubMed ID: 16219306
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.
    Belarbi K, Burnouf S, Fernandez-Gomez FJ, Laurent C, Lestavel S, Figeac M, Sultan A, Troquier L, Leboucher A, Caillierez R, Grosjean ME, Demeyer D, Obriot H, Brion I, Barbot B, Galas MC, Staels B, Humez S, Sergeant N, Schraen-Maschke S, Muhr-Tailleux A, Hamdane M, Buée L, Blum D.
    Neurobiol Dis; 2011 Aug 24; 43(2):486-94. PubMed ID: 21569847
    [Abstract] [Full Text] [Related]

  • 9. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
    Ando K, Leroy K, Heraud C, Kabova A, Yilmaz Z, Authelet M, Suain V, De Decker R, Brion JP.
    Biochem Soc Trans; 2010 Aug 24; 38(4):1001-5. PubMed ID: 20658993
    [Abstract] [Full Text] [Related]

  • 10. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.
    Kambe T, Motoi Y, Inoue R, Kojima N, Tada N, Kimura T, Sahara N, Yamashita S, Mizoroki T, Takashima A, Shimada K, Ishiguro K, Mizuma H, Onoe H, Mizuno Y, Hattori N.
    Neurobiol Dis; 2011 Jun 24; 42(3):404-14. PubMed ID: 21324362
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A, Sprenger F, Bayer TA, Wirths O.
    Neurobiol Aging; 2013 Nov 24; 34(11):2564-73. PubMed ID: 23747045
    [Abstract] [Full Text] [Related]

  • 13. Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model.
    Flunkert S, Hierzer M, Löffler T, Rabl R, Neddens J, Duller S, Schofield EL, Ward MA, Posch M, Jungwirth H, Windisch M, Hutter-Paier B.
    Neurodegener Dis; 2013 Nov 24; 11(4):194-205. PubMed ID: 22797329
    [Abstract] [Full Text] [Related]

  • 14. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J, Levy M, Dickson DW, Potter H.
    Brain; 2006 Nov 24; 129(Pt 11):3020-34. PubMed ID: 16987932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
    Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima K, Iwasaki K, Fujiwara M, Tanemura K, Murayama M, Ishiguro K, Planel E, Sato S, Hashikawa T, Takashima A.
    Proc Natl Acad Sci U S A; 2002 Oct 15; 99(21):13896-901. PubMed ID: 12368474
    [Abstract] [Full Text] [Related]

  • 18. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
    Lo AC, Iscru E, Blum D, Tesseur I, Callaerts-Vegh Z, Buée L, De Strooper B, Balschun D, D'Hooge R.
    J Alzheimers Dis; 2013 Oct 15; 37(1):109-25. PubMed ID: 23788007
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.